Brief: Paradigm Biopharmaceuticals Seeks Trading Halt
29/09/2022 23:42
Sept 30 (Reuters) - Paradigm Biopharmaceuticals Ltd
PAR.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON TO ANALYSE DATA
AND
PREPARE AN ASX ANNOUNCEMENT
Source text for Eikon: ID:nASX3nJtZ0
Further company coverage: PAR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Paradigm Biopharmaceuticals
See all newsBrief: Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration
Brief: Paradigm Biopharmaceuticals Seeks Trading Halt
Australia's Paradigm Biopharmaceuticals slips on discounted placement
Brief: Paradigm Biopharmaceuticals Says Co Completes A$14 Mln Placement
Brief: Paradigm Biopharmaceuticals Requests Trading Halt